Facing unprecedented pressure from the Trump administration, some of the world’s top drugmakers promise to cut prices. But experts say the savings might not be what they seem.

Guests:

• Michael Cannon, Director of Health Policy Studies, Cato Institute
• Stacie Dusetzina, Professor of Health Policy, Vanderbilt University
• Darius Lakdawalla, Chief Scientific Officer, USC Schaeffer Center
• Pete Loftus, Reporter, Wall Street Journal
• Ben Rome, Assistant Professor of Medicine, Harvard Medical School
• Leslie Walker, Senior Reporter, Tradeoffs

Learn more and read a full transcript on our website.

Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.

Support this type of journalism today, with a gift.

Hosted on Acast. See acast.com/privacy for more information.